회사 소개
- 법인명: Hybio Pharmaceutical Co.,Ltd
- 등록 국가: China
- 주소: Hybio Innovation Industry Building, , No. 7, Guansheng 4th Rd, , Guanlan High-tech Park,, Shenzhen
- 직원 수: 500 - 999
설명:
Founded in 1998, Hybio is a high-tech enterprise specializing in R&D and manufacturing of diverse peptide products, growing into a leading peptide pharmaceutical company and the first of its kind to go public in China (2011, stock code 300199). The company offers a full range of peptide products (API and finished dosage forms) and services (CRO and CDMO), with peptide finished products mainly sold domestically and peptide APIs supplied worldwide, and its Shenzhen headquarters has passed local and national NMPA GMP inspections more than 90 times.
사업 활동
원료의약품(API)
제조업체원료의약품 제조업체
완제 의약품
제조업체원료의약품 제조업체
오리지널 원료의약품
제조업체원료의약품 제조업체
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
주요 제품/서비스
당사 제품 & 서비스
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
인증
FDA
GMP
증거
CPHI Americas 2026
06/2026 – 06/2026
CPHI Americas 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기